Kurata Lance 4
4 · Arcturus Therapeutics Holdings Inc. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
Kurata Lance
Chief Legal Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-12-09+125,000→ 125,000 totalExercise: $16.92Exp: 2032-12-09→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock approved by the Board of Directors on December 9, 2022 pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
- [F2]The shares underlying this option vest 25% on December 9, 2023, the first anniversary of the date this award was approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.